SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Drugs Made In America Acquisition II Corp. Unit DMIIU NASDAQ

NASDAQ Global Select • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value

Negative cash flow

Drugs Made In America Acquisition II Corp. Unit (DMIIU) 有 7 个已识别的同行可供比较在 Financial Services 板块. 同行包括 EIC, GAIN, GAM, MSIF, NCDL, NEWT 等.

DMIIU 的市值为 $633.96M, 而同行平均市值为 $583.96M.

同行与相似公司 — DMIIU

Eagle Point Income Company Inc.

$9.82 +1.45% $230.42M

Gladstone Investment Corporation

$15.36 +1.45% $611.67M

General American Investors Company, Inc.

$62.90 +0.61% $1.47B

MSC Income Fund, Inc.

$12.89 +1.82% $604.68M

Nuveen Churchill Direct Lending Corp.

$14.42 +2.85% $712.16M

NewtekOne, Inc.

$12.73 +1.35% $367.74M

OFS Credit Company, Inc.

$2.98 -1.65% $86.68M

其他人也在看

General American Investors Company, Inc.

Nuveen Churchill Direct Lending Corp.

Gladstone Investment Corporation

MSC Income Fund, Inc.

NewtekOne, Inc.

Eagle Point Income Company Inc.

OFS Credit Company, Inc.

Vanguard Total Stock Market Index Fund Institutional Shares

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言